Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development

Hai Wu, Shih Chu Kao, Tomasa Barrientos, Scott H. Baldwin, Eric N. Olson, Gerald R. Crabtree, Bin Zhou, Ching Pin Chang

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Patients with Down syndrome have characteristic heart valve lesions resulting from endocardial cushion defects. The Down syndrome critical region 1 (DSCR1) gene, identified at the conserved trisomic 21 region in those patients, encodes a calcineurin inhibitor that inactivates nuclear factor of activated T cells (NFATc) activity. Here, we identify a regulatory sequence in the promoter region of human DSCR1 that dictates specific expression of a reporter gene in the endocardium, defined by the temporal and spatial expression of Nfatc1 during heart valve development. Activation of this evolutionally conserved DSCR1 regulatory sequence requires calcineurin and NFATc1 signaling in the endocardium. NFATc1 proteins bind to the regulatory sequence and trigger its enhancer activity. NFATc1 is sufficient to induce the expression of Dscr1 in cells that normally have undetectable or minimal NFATc1 or DSCR1. Pharmacologic inhibition of calcineurin or genetic Nfatc1 null mutation in mice abolishes the endocardial activity of this DSCR1 enhancer. Furthermore, in mice lacking endocardial NFATc1, the endogenous Dscr1 expression is specifically inhibited in the endocardium but not in the myocardium. Thus, our studies indicate that the DSCR1 gene is a direct transcriptional target of NFATc1 proteins within the endocardium during a critical window of heart valve formation.

Original languageEnglish (US)
Pages (from-to)30673-30679
Number of pages7
JournalJournal of Biological Chemistry
Volume282
Issue number42
DOIs
StatePublished - Oct 19 2007
Externally publishedYes

Fingerprint

NFATC Transcription Factors
Endocardium
Genes
Calcineurin
Heart Valves
Genetic Promoter Regions
Proteins
Endocardial Cushion Defects
Chemical activation
Defects
Down Syndrome
Reporter Genes
Down Syndrome Critical Region
Myocardium
Mutation

ASJC Scopus subject areas

  • Biochemistry

Cite this

Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development. / Wu, Hai; Kao, Shih Chu; Barrientos, Tomasa; Baldwin, Scott H.; Olson, Eric N.; Crabtree, Gerald R.; Zhou, Bin; Chang, Ching Pin.

In: Journal of Biological Chemistry, Vol. 282, No. 42, 19.10.2007, p. 30673-30679.

Research output: Contribution to journalArticle

Wu, Hai ; Kao, Shih Chu ; Barrientos, Tomasa ; Baldwin, Scott H. ; Olson, Eric N. ; Crabtree, Gerald R. ; Zhou, Bin ; Chang, Ching Pin. / Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development. In: Journal of Biological Chemistry. 2007 ; Vol. 282, No. 42. pp. 30673-30679.
@article{ea6235f0a54948ed8b229b194dafa652,
title = "Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development",
abstract = "Patients with Down syndrome have characteristic heart valve lesions resulting from endocardial cushion defects. The Down syndrome critical region 1 (DSCR1) gene, identified at the conserved trisomic 21 region in those patients, encodes a calcineurin inhibitor that inactivates nuclear factor of activated T cells (NFATc) activity. Here, we identify a regulatory sequence in the promoter region of human DSCR1 that dictates specific expression of a reporter gene in the endocardium, defined by the temporal and spatial expression of Nfatc1 during heart valve development. Activation of this evolutionally conserved DSCR1 regulatory sequence requires calcineurin and NFATc1 signaling in the endocardium. NFATc1 proteins bind to the regulatory sequence and trigger its enhancer activity. NFATc1 is sufficient to induce the expression of Dscr1 in cells that normally have undetectable or minimal NFATc1 or DSCR1. Pharmacologic inhibition of calcineurin or genetic Nfatc1 null mutation in mice abolishes the endocardial activity of this DSCR1 enhancer. Furthermore, in mice lacking endocardial NFATc1, the endogenous Dscr1 expression is specifically inhibited in the endocardium but not in the myocardium. Thus, our studies indicate that the DSCR1 gene is a direct transcriptional target of NFATc1 proteins within the endocardium during a critical window of heart valve formation.",
author = "Hai Wu and Kao, {Shih Chu} and Tomasa Barrientos and Baldwin, {Scott H.} and Olson, {Eric N.} and Crabtree, {Gerald R.} and Bin Zhou and Chang, {Ching Pin}",
year = "2007",
month = "10",
day = "19",
doi = "10.1074/jbc.M703622200",
language = "English (US)",
volume = "282",
pages = "30673--30679",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "42",

}

TY - JOUR

T1 - Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development

AU - Wu, Hai

AU - Kao, Shih Chu

AU - Barrientos, Tomasa

AU - Baldwin, Scott H.

AU - Olson, Eric N.

AU - Crabtree, Gerald R.

AU - Zhou, Bin

AU - Chang, Ching Pin

PY - 2007/10/19

Y1 - 2007/10/19

N2 - Patients with Down syndrome have characteristic heart valve lesions resulting from endocardial cushion defects. The Down syndrome critical region 1 (DSCR1) gene, identified at the conserved trisomic 21 region in those patients, encodes a calcineurin inhibitor that inactivates nuclear factor of activated T cells (NFATc) activity. Here, we identify a regulatory sequence in the promoter region of human DSCR1 that dictates specific expression of a reporter gene in the endocardium, defined by the temporal and spatial expression of Nfatc1 during heart valve development. Activation of this evolutionally conserved DSCR1 regulatory sequence requires calcineurin and NFATc1 signaling in the endocardium. NFATc1 proteins bind to the regulatory sequence and trigger its enhancer activity. NFATc1 is sufficient to induce the expression of Dscr1 in cells that normally have undetectable or minimal NFATc1 or DSCR1. Pharmacologic inhibition of calcineurin or genetic Nfatc1 null mutation in mice abolishes the endocardial activity of this DSCR1 enhancer. Furthermore, in mice lacking endocardial NFATc1, the endogenous Dscr1 expression is specifically inhibited in the endocardium but not in the myocardium. Thus, our studies indicate that the DSCR1 gene is a direct transcriptional target of NFATc1 proteins within the endocardium during a critical window of heart valve formation.

AB - Patients with Down syndrome have characteristic heart valve lesions resulting from endocardial cushion defects. The Down syndrome critical region 1 (DSCR1) gene, identified at the conserved trisomic 21 region in those patients, encodes a calcineurin inhibitor that inactivates nuclear factor of activated T cells (NFATc) activity. Here, we identify a regulatory sequence in the promoter region of human DSCR1 that dictates specific expression of a reporter gene in the endocardium, defined by the temporal and spatial expression of Nfatc1 during heart valve development. Activation of this evolutionally conserved DSCR1 regulatory sequence requires calcineurin and NFATc1 signaling in the endocardium. NFATc1 proteins bind to the regulatory sequence and trigger its enhancer activity. NFATc1 is sufficient to induce the expression of Dscr1 in cells that normally have undetectable or minimal NFATc1 or DSCR1. Pharmacologic inhibition of calcineurin or genetic Nfatc1 null mutation in mice abolishes the endocardial activity of this DSCR1 enhancer. Furthermore, in mice lacking endocardial NFATc1, the endogenous Dscr1 expression is specifically inhibited in the endocardium but not in the myocardium. Thus, our studies indicate that the DSCR1 gene is a direct transcriptional target of NFATc1 proteins within the endocardium during a critical window of heart valve formation.

UR - http://www.scopus.com/inward/record.url?scp=35648949357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648949357&partnerID=8YFLogxK

U2 - 10.1074/jbc.M703622200

DO - 10.1074/jbc.M703622200

M3 - Article

C2 - 17693409

AN - SCOPUS:35648949357

VL - 282

SP - 30673

EP - 30679

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 42

ER -